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Abstract
Hypoxia Inducible Factor-1 (HIF-1) is essential for mammalian development and is the principal transcription factor activated
by low oxygen tensions. HIF-a subunit quantities and their associated activity are regulated in a post-translational manner,
through the concerted action of a class of enzymes called Prolyl Hydroxylases (PHDs) and Factor Inhibiting HIF (FIH)
respectively. However, alternative modes of HIF-a regulation such as translation or transcription are under-investigated, and
their importance has not been firmly established. Here, we demonstrate that NF-kB regulates the HIF pathway in a
significant and evolutionary conserved manner. We demonstrate that NF-kB directly regulates HIF-1b mRNA and protein. In
addition, we found that NF-kB–mediated changes in HIF-1b result in modulation of HIF-2a protein. HIF-1b overexpression
can rescue HIF-2a protein levels following NF-kB depletion. Significantly, NF-kB regulates HIF-1b (tango) and HIF-a (sima)
levels and activity (Hph/fatiga, ImpL3/ldha) in Drosophila, both in normoxia and hypoxia, indicating an evolutionary
conserved mode of regulation. These results reveal a novel mechanism of HIF regulation, with impact in the development of
novel therapeutic strategies for HIF–related pathologies including ageing, ischemia, and cancer.
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Introduction
Hypoxia Inducible Factor-1 (HIF-1) is a transcription factor
which is part of a stress response mechanism that is initiated in the
presence of low oxygen tensions. Moreover, HIF has been
demonstrated to play key roles in development, physiological
processes and pathological conditions as its presence affects cell
cycle progression, survival, and metabolism [1,2]. The a subunits
are mostly controlled post translationally, through the concerted
action of a class of enzymes called Prolyl Hydroxylases (PHD1, 2
and 3). The proline hydroxylation of HIF-a, subsequently target
the a subunit for VHL-dependent 26S-proteosomal degradation
[3]. The oxygen dependent mechanism of HIF-a control is
conserved in organisms such as worms [4–6] and flies [4,7–9], with
homologues of HIF-a, HIF-1b and PHD being identified in these
organisms. Multiple studies have thus demonstrated the impor-
tance of the O2 and PHD-dependent control mechanism in an
evolutionary context.
Although predominantly studied following hypoxic stress, HIF-
a stabilisation is also found in non-hypoxic conditions through
largely uncharacterised mechanisms [10,11]. However, recent
studies have demonstrated that control of the HIF-1a gene by NF-
kB provides an important, additional and parallel level of
regulation over the HIF-1a pathway [12–15]. In the absence of
NF-kB, the HIF-1a gene is not transcribed and hence no
stabilisation and activity is seen even after prolonged hypoxia
exposures [14,15]. NF-kB is the collective name for a transcription
factor that exists as either a hetero- or homo-dimeric complex.
The family of Rel homology domain containing genes (NF-kB) is
composed of RelA (p65), RelB, cRel, p50 and its precursor p105
(NF-kB 1), and p52 and its precursor p100 (NF-kB 2). These
subunits are predominantly sequestered in the inactive state in the
cytoplasm, by members of the IkB family [16]. Upon activation,
by compounds such as TNF-a, oncogenes or UV light; a kinase
signaling cascade results in the IKK mediated phosphorylation of
IkB and its subsequent poly-ubiquitin mediated proteasomal
degradation. This allows for NF-kB release and translocation into
the nucleus and binding to target gene promoters and enhancers
[16–18]. Aberrantly active NF-kB has been associated with a
number of human diseases, stimulating the pharmaceutical
industry’s interest in finding potential applications for NF-kB
inhibition [19]. NF-kB homologues have been found in a number
of species from sea squirt, frogs to flies (www.NF-kB.org).
Significantly, NF-kB function in the immune system was greatly
propelled by studies in Drosophila, where genetics helped delineate
NF-kB’s contribution to this important process [20,21].
Here, we have investigated the role of NF-kB in the control of
the HIF pathway. We find that NF-kB controls HIF-1b and HIF-a
levels in response to cytokine stimulation in both human and
mouse cells. Importantly, we demonstrate that NF-kB controls
HIF levels and activity in Drosophila. These results indicate that in
likeness to the oxygen dependent regulation of HIF, NF-kB
dependent control is an important and evolutionary conserved
pathway. Furthermore, it places the HIF system as a downstream
effector of NF-kB biological functions.
Results
TNF-a increases HIF-1b and HIF-2a protein expression
HIF is a major transcription factor responding to changes in
oxygen levels within the cell [1]. However, it is also induced in
normal oxygen conditions in response to cytokines and oncogene
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activation [14]. A few studies have demonstrated that one of the
mechanisms behind HIF activation in normoxia, occurs via
increases in transcription of the HIF-1a gene [12–15]. We
investigated how the HIF system as a whole responds to cytokine
stimulation. For this purpose, a time course analysis of nuclear
extracts, from cells previously exposed to TNF-a, was performed,
and the levels of HIF-1b and HIF-2a were analysed by western
blot (Figure 1A). We observed an increase in the nuclear levels of
both HIF-1b and HIF-2a in response to TNF-a (Figure 1A). This
could be explained by either an increase in nuclear translocation of
these proteins, or an increase in the total levels. To discern
between these options, whole cell lysates were also analysed for the
levels of these proteins in response to TNF-a. TNF-a treatment
resulted in increased total protein levels of both HIF-1b and HIF-
2a (Figure 1B) in both cell lines tested.
TNF-a increases HIF-1b but not HIF-2a transcript levels
To investigate the mechanism behind HIF-1b and HIF-2a
protein increases, the mRNA levels of these two genes following
TNF-a exposure were analysed. qRT-PCR analysis indicated that
in HEK293 cells or in HeLa cells, TNF-a treatment does not
result in any significant increases of HIF-2a mRNA (Figure 1C).
However, we found that HIF-1b transcript levels were induced in
response to TNF-a in both cell types (Figure 1C).
IKK and NF-kB are required for TNF-a induction of HIF-1b
mRNA
TNF-a activates the classical activation pathway that requires
the IKK complex [17]. To test if TNF-a induced HIF-1b mRNA
was due to IKK-dependent activation of NF-kB, cells were pre-
treated with the IKK inhibitor Bay 11 7082 for 30 minutes, prior
to TNF-a treatment. Total RNA was extracted and HIF-1b
mRNA was measured using qRT-PCR. When IKK was inhibited
TNF-a induced HIF-1b mRNA was greatly reduced (Figure 2A).
Once again, we did not observe any effects of TNF-a on HIF-2a
mRNA in the presence or absence of IKK activity. A significant
reduction in the NF-kB subunit and RelA target, p100 mRNA in
response to TNF-a, was also seen when IKK was inhibited
(Figure 2A).
As IKK has NF-kB independent functions [22], we investigated
the role of NF-kB in the control of HIF-1b. Using siRNA
mediated depletion of RelA, TNF-a treatment was performed and
the effects on the levels of HIF-1b and HIF-2a were analysed by
qRT-PCR. The siRNA treatment was very effective at reducing
the levels of RelA (Figure 2B). Importantly, depletion of RelA
significantly impaired TNF-a mediated induction of HIF-1b and
p100 mRNA (Figure 2B). HIF-2a mRNA levels were unaffected
by RelA depletion in untreated and TNF-a treated cells
(Figure 2B).
Since, RelA depletion only partially prevented TNF-a induction
of HIF-1b, we assessed if other NF-kB subunits were also involved
in this process. For this purpose, we targeted all NF-kB subunits
concurrently, using a siRNA oligonucleotide directed against the
Rel homology domain. This siRNA reduced the levels of all
subunits of the NF-kB family (Figure S1A). Using RT-qPCR we
analysed the levels of HIF-1b in both HEK293 and HeLa cells
(Figure 3A). Importantly, depletion of all NF-kB subunits
prevented TNF-a mediated induction of HIF-1b in both cell
systems (Figure 3A). In addition it prevented the induction of HIF
target genes such as GLUT3 and PGK1 (Figure 3B). As expected
we did not observe any significant change in HIF-2a mRNA levels
(Figure S1B). Consistent with our previous work, HIF-1a mRNA
was also significantly decreased in the absence of NF-kB (Figure
S1C) [14,15]. These results support our finding with the IKK
inhibitor and RelA depletion in addition to confirming an
appreciable level of redundancy within the NF-kB pathway.
Taken together these results suggest that IKK-dependent
activation of NF-kB, mediates the induction of HIF-1b mRNA
following TNF-a treatment.
HIF-1b is a novel NF-kB target
TNF-a treatment induced HIF-1b protein and mRNA in an
IKK-NF-kB dependent manner (Figure 1, Figure 2, Figure 3). As
NF-kB is a transcription factor, we wanted to determine if this
control was direct. Therefore, we analysed the HIF-1b promoter
for possible NF-kB binding sites, using MatInspector (www.
genomatix.de). Our analysis revealed that there are three putative
NF-kB binding sites, which are located at –36 bp, 59 bp, and
354 bp from the transcription start site. We designed primer sets
encompassing these sites as well as a negative control region within
the first intronic region of the gene. Chromatin Immunoprecip-
itation assays using antibodies specific for NF-kB subunits were
used in extracts derived from cells untreated or treated with TNF-
a for 24 h. PCRs were performed using two sets of primers and
products were resolved on agarose gels. The results show that
RelA is actively recruited to site 1 within the HIF-1b promoter
following TNF-a treatment, while no binding was observed when
the control region of the HIF-1b gene was analysed (Figure 4A).
Furthermore, recruitment of an active marker of transcription,
polymerase II, was also observed at the HIF-1b promoter regions
where the NF-kB binding sites are located, following TNF-a
treatment (Figure 4B).
As we had observed an active recruitment of NF-kB to the HIF-
1b promoter following TNF-a treatment, we sought to formally
demonstrate this occurred in an IKK-dependent manner. As such,
cells were treated with the IKK inhibitor Bay 11 7082, prior to
treatment with TNF-a and ChIPs were performed. TNF-a-
dependent recruitment of RelA to the HIF-1b promoter was
impaired in cells where IKK activity was reduced (Figure 4C). In
addition, we could detect an IKK-dependent increase in binding
of p50, c-Rel and p52 to the HIF-1b promoter (Figure S2A, S2B,
S2C).
Author Summary
The mechanisms by which cells and organisms respond to
oxygen are of extreme importance for development and
also for certain pathologies such as cancer, ageing, and
ischemia. These are mediated by a family of transcription
factors called hypoxia inducible factor (HIF), a factor that
coordinates expression of a great number of genes.
Significantly, these processes are evolutionary conserved
from worms to humans. It is known that regulation of HIF
occurs to a great extent through protein degradation.
However, other important mechanisms of HIF control are
currently being investigated. In this study, we have
uncovered a novel mechanism of HIF regulation that relies
on the action of another transcription factor family called
NF-kB. We have found that NF-kB controls the levels of
HIF-1a and HIF-1b genes by direct regulation. Further-
more, through its control of HIF-1b, NF-kB indirectly
controls HIF-2a. Importantly, we find that this mechanism
is conserved in Drosophila and mice. These results suggest
an alternative avenue for therapeutic intervention in the
HIF pathway, which has important implications for many
human diseases.
NF-kB Regulates HIF-1b and HIF-2a
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Figure 1. TNF-a induces HIF-1b and HIF-2a protein but only HIF-1b mRNA. (A) HEK293 were treated with 20 ng/mL TNF-a for the indicated
times prior to nuclear extraction. Levels of HIF-2a and HIF-1b were analysed by Western Blot. PCNA was used as a loading control. (B) HEK293 and
HeLa cells were treated as in A, prior to lysis. Whole cell lysates were analysed by Western Blot. (C) HEK293 and HeLa cells were treated with 20 ng/mL
TNF-a for the indicated periods of times prior to total RNA extraction. Following cDNA synthesis, qPCR was performed for the levels of HIF-2a and
HIF-1b.
doi:10.1371/journal.pgen.1001285.g001
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To determine the functional significance of the IKK-dependent
recruitment of NF-kB to the HIF-1b promoter region, we
examined if TNF-a induced polymerase loading was affected by
IKK inhibition (Figure 4D). When the NF-kB pathway is
inhibited, RNA polymerase II recruitment to the HIF-1b
promoter is severely impaired (Figure 4D), indicating that NF-
kB is a necessary factor for the formation of the RNA polymerase
II transcriptional complex. These data show a direct regulation of
the HIF-1b promoter by NF-kB.
IKK and NF-kB are required for TNF-a induced HIF-1b and
HIF-2a protein
Our results indicate that changing NF-kB activity and levels
results in altered HIF-1b mRNA. We wanted to determine if this
was also seen at the protein level. HeLa cells were treated with
IKK inhibitor prior to treatment with TNF-a. Analysis of the
whole cell lysates demonstrated that in the absence of IKK
activity, TNF-a treatment failed to induce HIF-1b expression
(Figure 5A). These results support our mRNA analysis, where IKK
inhibition resulted in impaired TNF-a induced HIF-1b
(Figure 2A). We also analysed HIF-2a protein levels. Interestingly,
inhibition of IKK also prevented TNF-a induced HIF-2a protein.
These results suggest that IKK is controlling HIF-2a through a
protein stabilisation mechanism and not as a result of increased
HIF-2a mRNA production (Figure 2A and Figure 5A).
To further demonstrate the involvement of NF-kB in the
control of HIF-1b and HIF-2a proteins, NF-kB subunits were
depleted by siRNA (Figure 5B). Under conditions of NF-kB
impairment, TNF-a treatment did not increase HIF-1b, HIF-1a
or, HIF-2a protein levels in HeLa or HEK293 cells (Figure 5B).
Figure 2. TNF-a–induced HIF-1b mRNA is IKK- and RelA-dependent. (A) HEK293 cells were pre-treated with the IKK inhibitor Bay 11 7082
prior to treatment with 20 ng/mL TNF-a for the indicated times. Total RNA was extracted, converted to cDNA, and qPCR was performed for the levels
of HIF-1b, HIF-2a and p100. (B) HEK293 cells were transfected with control and RelA siRNA oligonucleotides for a total of 72 hours. Where indicated
cells were treated with 20 ng/mL TNF-a prior to total RNA extraction. qPCR was performed for the levels of HIF-1b, HIF-2a, p100 and RelA.
doi:10.1371/journal.pgen.1001285.g002
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Figure 3. TNF-a–induced HIF mRNA levels and activity are NF-kB–dependent. (A) HEK293 and HeLa cells were transfected with control and
pan-NF-kB siRNA oligonucleotides for a total of 72 hours. Where indicated cells were treated with 20 ng/mL TNF-a prior to total RNA extraction. qPCR
was performed for the levels of HIF-1b. (B) Cells were treated and processed as in A, and qPCR was performed for the indicated genes.
doi:10.1371/journal.pgen.1001285.g003
NF-kB Regulates HIF-1b and HIF-2a
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Figure 4. TNF-a induces RelA and RNA polymerase II recruitment to the HIF-1b promoter. (A) HEK293 and HeLa cells were treated with
20 ng/mL TNF-a for 24 hours prior to crosslinking and lysis. ChIPs were performed using the indicated antibodies and purified DNA was amplified
using PCR primers for the HIF-1b promoter and control regions. The IkB-a promoter was used as a positive control. (B) ChIPs were performed for RNA
polymerase II and purified DNA processed as in A. (C) HeLa cells were pre-treated with the IKK inhibitor Bay 11 7082 for 30 minutes prior to TNF-a
treatment. Cells were crosslinked and lysed 24 hours later. ChIPs were performed for the levels of RelA. (D) ChIPs were performed for RNA polymerase
II and purified DNA processed as in A. IkB-a promoter was used as a positive control.
doi:10.1371/journal.pgen.1001285.g004
NF-kB Regulates HIF-1b and HIF-2a
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Taken together these results indicate that IKK-NF-kB control
HIF-1b, HIF-1a and HIF-2a proteins.
Changes in HIF-1b alter HIF-2a protein levels and result
in AHR inhibition
TNF-a induces increases in HIF-1a [14], HIF-1b, and HIF-2a
(Figure 1, Figure 5). We have demonstrated that HIF-1a and HIF-
1b increases are both transcriptional ([14], Figure 2, Figure 3,
Figure 4, Figure 5, Figure 6). However, we could not establish a
direct link between NF-kB and HIF-2a. To investigate the
mechanism behind HIF-2a stabilisation, we hypothesised that this
was due to increased levels of its binding partner HIF-1b. HIF-1b
increases could provide HIF-2a protection from proteolytic
degradation. To test this hypothesis, we depleted HIF-1b directly,
treated with TNF-a and analysed HIF-2a levels. In the absence of
HIF-1b, TNF-a treatment did not result in any visible increases of
HIF-2a protein in both HEK293 and HeLa cells (Figure 6A).
These results suggest that HIF-1b levels can modulate HIF-2a
subunit protein levels. Similar results were also obtained for HIF-
1a, in U2OS cells exposed to hypoxia (Figure S3). To further
investigate this mechanism, we performed gain of function
experiments, where we overexpressed HIF-1b in the absence of
any additional treatment. We could observe a dose dependent
increase of HIF-1b as expected (Figure 6B). Importantly, this was
also evident in the levels of HIF-2a protein (Figure 6B). Taken
together these results indicate that HIF-1b is necessary and
sufficient for the stabilisation of HIF-2a.
We have found that NF-kB mediates the TNF-a induction of
HIF-1b mRNA and protein. In addition, gain and loss of function
experiments, presented in Figure 6A and 6B, demonstrate that
modulation of HIF-1b levels has a direct impact on HIF-2a
protein levels. To specifically demonstrate that NF-kB induction of
HIF-2a protein is dependent on HIF-1b levels, we performed NF-
kB depletion by siRNA and simultaneously increased HIF-1b by
exogenous overexpression. Cell extracts were analysed for both
HIF-1b and HIF-2a levels by western blot (Figure 6C). Our
analysis revealed that HIF-1b overexpression is sufficient to rescue
the effects of NF-kB depletion on HIF-2a levels (Figure 6C).
Apart from binding HIF-a subunits, HIF-1b also binds the
transcription factor Aryl Hydrocarbon Receptor (AHR) [23].
AHR is responsible for activating genes involved in detoxification
and xenobiotic metabolism [23]. To determine if TNF-a induced
HIF-1b and consequentially HIF-1a and HIF-2a had any
functional significance in the modulation of AHR, we analysed if
HIF-1b changed binding partners under these conditions. We co-
immunoprecipitated HIF-1b and determined the levels of
Figure 5. TNF-a–induced HIF-1b and HIF-2a proteins are IKK- and NF-kB–dependent. (A) HeLa cells were transfected with control or pan-
NF-kB siRNA oligonucleotides and cultured for a total of 48 hours. Whole cell lysates were analysed by Western blot for the proteins mentioned. (B)
HeLa cells were pre-treated with the IKK inhibitor Bay 11 7082 for 30 minutes prior to TNF-a treatment for the indicated periods of time prior to lysis.
Whole cell lysates were analysed by Western blot for the proteins mentioned. (C) HEK293 and HeLa cells were transfected with control or pan-NF-kB
siRNA oligonucleotides and cultured for a total of 72 hours. Where indicated, cells were treated with 20 ng/mL TNF-a prior to lysis. Whole cell lysates
were analysed by Western blot for the proteins mentioned.
doi:10.1371/journal.pgen.1001285.g005
NF-kB Regulates HIF-1b and HIF-2a
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Figure 6. HIF-1b is required for TNF-a–induced HIF-2a, which represses AHR function. (A) HEK293 and HeLa cells were transfected with
control or HIF-1b siRNA oligonucleotides and cultured for a total of 72 hours. Where indicated cells were treated with 20 ng/mL TNF-a prior to lysis.
Whole cell lysates were analysed by Western blot for the proteins mentioned. (B) HEK293 cells were transfected with increasing amount of HIF-1b
expression plasmid for 48 hours prior to lysates. Whole cell lysates were analysed by Western blot for the indicated proteins. (C) HEK293 cells were
transfected with control or pan-NF-kB siRNA oligonucleotides and cultured for 72 hours. Where indicated cells were co-transfected with HIF-1b
expression plasmids. Whole cell lysates were analysed by Western blot for the mentioned proteins. (D) HeLa cells were left untreated (Ctl) treated
with 20 ng/mL TNF-a (T) or 1% O2 (H) for 24 hours prior to lysis. 200 mg of protein were used to immunoprecipitate HIF-1b. Levels of associated
proteins were assessed by western blot using the indicated antibodies. Input corresponds to 10% of starting material. (E) HeLa cells were transfected
with control, HIF-1a or HIF-2a siRNA oligonucleotides for a total of 48 hours. Where indicated cells were treated with 20 ng/mL TNF-a prior to total
RNA extraction. qPCR was performed for the levels of the indicated genes.
doi:10.1371/journal.pgen.1001285.g006
NF-kB Regulates HIF-1b and HIF-2a
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associated HIF-1a and AHR (Figure 6D). Under non-stimulated
conditions, HIF-1b is significantly associated with AHR
(Figure 6D, lane 7), however following TNF-a or hypoxia HIF-
1b dissociates from AHR (Figure 6D, lane 8 and 9). This suggests
that in response to TNF-a or hypoxia AHR function is reduced.
To test this hypothesis, we assessed if TNF-a treatment had any
effect on the levels of two AHR target genes, CYP1A1 and
CYP1B1 (Figure S4A). Our analysis revealed that TNF-a
treatment resulted in a time-dependent reduction in the levels of
these two genes. Given that TNF-a induces HIF activity and a
dissociation of HIF-1b from AHR, we assessed if the levels of
CYP1A1 and CYP1B1 could be rescued by HIF-a depletion
(Figure 6E). HIF-a depletion was effectively achieved (Figure S4B).
Interestingly, the levels of CYP1A1 and CYP1B1 were not
reduced by TNF-a treatment when HIF-2a was depleted.
Knockdown of HIF-1a resulted in a partial recovery of these
two genes (Figure 6E). Taken together these results indicate that
TNF-a induced HIF-1b results in higher HIF-a activity and
reduced AHR function, suggesting an impaired xenobiotic
metabolism.
NF-kB mediated control of the HIF pathway is conserved
in mouse and Drosophila
Alignment of the human and mouse HIF-1b promoter region
revealed that these are well conserved (Figure S2C). Therefore, we
hypothesised that in a murine model HIF-1b was likely to show a
similar dependence on NF-kB. To test this hypothesis, Mouse
Embryonic Fibroblasts (MEFs) were treated with TNF-a, and
HIF-1b levels were analysed (Figure 7A). HIF-1b levels were
increased after 24 hours of treatment. In addition, we treated
MEFs with an IKK inhibitor (BAY11 7082) for 24 hours. Whole
cell lysates were analysed by western blot and the results show that
when NF-kB is inhibited, HIF-1b protein level is reduced
(Figure 7B). In addition, analysis of IKKb or IKKa/b null MEFs
also revealed a reduction in HIF-1b levels when compared with
wildtype MEFs (Figure 7C). Finally, we performed depletion of
IKK subunits by siRNA in MEFs (Figure 7D). While depletion of
IKKa and IKKb did not alter the levels of HIF-1b, knockdown of
IKKc resulted in a visible decrease of the HIF-1b protein
(Figure 7D). These results suggest that NF-kB dependent
transcription of HIF-1b is conserved in mice.
Figure 7. NF-kB–mediated control of the HIF system is conserved in mice. (A) Mouse embryo fibroblasts (MEFs) were treated with 20 ng/mL
TNF-a for the indicated period of time prior to lysis. Whole cell lysates were analysed by Western blot. (B) MEFs were treated with the IKK inhibitor for
24 hours prior to lysis. Whole cell lysates were analysed by Western blot for the levels of HIF-1b. (C) Whole cell lysates were obtained from IKK
wildtype (WT), IKKb-/- or IKKa/b-/- MEFs and analysed by western blots. (D) MEFs were transfected with siRNA oligonucleotides for IKKa, IKKb or IKKc
and the levels of HIF-1b were analysed by western blot.
doi:10.1371/journal.pgen.1001285.g007
NF-kB Regulates HIF-1b and HIF-2a
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NF-kB and HIF are also conserved in insects [4,20]. The
Drosophila genome encodes three NF-kB family members, Dorsal,
Dif and Relish [21], and HIF homologues are encoded by the
genes similar (sima; HIF-1a) and tango (HIF-1b) [4]. To test if the
NF-kB-mediated regulation of the HIF pathway is also conserved
and hence important in Drosophila, we analysed the levels of HIF-
1a and HIF-1b mRNA, as well as the HIF target PHD/Fatiga
(encoded by Hph in Drosophila) levels in control and flies mutant for
loss-of-function alleles of dorsal (Figure 8A). Our analysis revealed
that in dorsal mutant flies, both sima and tango mRNA levels are
significantly reduced compared to wildType controls (Figure 8A),
while an unrelated gene, Iswi, is unaffected in dorsal mutants.
Importantly, the levels of the HIF target and PHD2 homologue
Hph/fatiga are also reduced (Figure 8A), indicating that the
changes observed in mRNA are also functionality translated into
lower target gene activation.
Given that Drosophila possesses two additional NF-kB members
(Dif and Relish), we next determined if these also contributed to
the control of HIF levels and activity in the fly. While loss of dif,
resulted in reduced levels of sima and tango, it had no effect in the
levels of the target genes Hph/fatiga and ImpL3/ldha (Figure 8B).
On the other hand, loss of relish resulted in higher levels of sima and
tango and also Sima targets Hph/fatiga and ImpL3/ldha, suggesting
that relish acts as a repressor of these genes.
To further analyse the role of NF-kB in the control of the HIF
system in Drosophila, we performed gain of function experiments
using ubiquitous overexpression of dorsal, and flies hemizygous for
a loss of function allele of cactus, the fly homologue of IkB. In both
of these genotypes, we observed an increase in the levels of sima
and tango and their target genes Hph/fatiga and ImpL3/ldha
(Figure 8C). These data suggest that activated Dorsal is able to
induce the expression of HIF in the fly.
A recent study using Drosophila S2 cells has demonstrated that
hypoxia induces increases in sima mRNA [24]. Given our findings,
we next assessed if in adult flies, NF-kB was responsible for
hypoxia induced sima mRNA and activity. For this purpose, we
exposed adult flies to 5% O2 for 24 hours prior to mRNA
extraction. We could confirm that like in S2 cells, hypoxia induces
sima mRNA production in adult flies (Figure 8D). Interestingly, we
also observed a significant increase in tango mRNA (Figure 8D).
Importantly, these responses were abolished in dorsal loss of
function flies (Figure 8D). Significantly, levels of the HIF target
genes, Hph/fatiga and ImpL3/ldha, following hypoxia exposure,
were significantly reduced in the absence of dorsal (Figure 8E).
These results demonstrate that Dorsal is required for basal and
hypoxia-induced HIF levels and activity in Drosophila.
All together our data demonstrate a novel control mechanism
over the HIF system. By controlling HIF-1b, NF-kB is able to
indirectly induce HIF-2a and thus has multiple levels of control
over the HIF pathway (Figure 8F). Importantly, this is an
evolutionary conserved mechanism, observed from flies to
humans.
Discussion
In this report we demonstrate an evolutionary conserved and
important mode of regulation of the HIF pathway by the
transcription factor family NF-kB. We show that NF-kB can
control the HIF pathway through several different mechanisms.
Our results demonstrate that, in response to TNF-a, NF-kB
controls the HIF-1b promoter directly (Figure 4). Depletion or
inhibition of NF-kB activity results in low levels of HIF-1b and
importantly, HIF-a proteins (Figure 6, Figure 7). Interestingly, we
have identified a mechanism by which NF-kB can control HIF-2a
levels and activity. We show that HIF-1b is necessary and
sufficient for HIF-a stability in normoxia and hypoxia (Figure 6).
Significantly, we show that NF-kB-mediated regulation of the HIF
system is conserved in mice and Drosophila (Figure 7, Figure 8).
It is well established that HIF-a subunits are tightly regulated in
the cell. However, very few studies have investigated how HIF-1b
is controlled, or if it responds to stimulation. Yet, HIF-1b
importance for development, homeostasis and disease is under-
scored by the numerous studies where HIF-1b is deleted,
systemically or conditionally [25-30]. Systemic deletion of HIF-
1b results in very early embryonic lethality with defects in
placental, yolk sac and hemapoetic vascularization [30]. Condi-
tional deletion of HIF-1b has demonstrated important roles in skin
and liver [25,26,28].
HIF-1b is also known as Aryl Hydrocarbon Nuclear Translo-
cator (ARNT), and apart from binding HIF-a subunits it is also an
important binding partner for other transcription factors such as
Aryl Hydrocarbon Receptor (AHR), a central regulator of
xenobiotic metabolism [23]. As such, HIF-1b plays a role in both
hypoxic and xenobiotic responses [31]. Importantly, several
studies have demonstrated that ARNT has higher affinity for the
HIF-a subunits, hence hypoxia induces a displacement of ARNT
from AHR [32]. Furthermore, hypoxia or HIF-a stabilisation
leads to inhibition of AHR activity [33,34].
From our results, it would be predicted that NF-kB activation
by TNF-a, apart from increasing HIF-1b and HIF-a subunits,
would lead to the inhibition of AHR response. TNF-a and NF-kB
have been shown previously to repress the expression of certain
AHR targets such as CYP1A1, however, the mechanism behind
such repression is not fully understood [35,36]. We have thus
investigated this possibility. Our results demonstrate that TNF-a
induces the displacement of ARNT from AHR to HIF-a
(Figure 6D). Furthermore, we show that as published previously
[35,36], TNF-a induces repression of AHR targets such as
CYP1A1 and CYP1B1 (Figure 6E and Figure S4A). Importantly,
this can be prevented by depletion of HIF-2a and, to some extent,
by depletion of HIF-1a. These results indicate that hypoxia or
inflammation will lead to a lowering of AHR activity and hence
reduced xenobiotic metabolism.
Our results demonstrate a mechanism by which NF-kB can
indirectly regulate HIF-2a protein levels. These events take place
in normoxia, indicating a PHD independent mechanism. A few
reports have analysed PHD-independent HIF-a degradation
pathways. Amongst these, HSP90 and RACK1 compete for
HIF-1a binding and hence modulate stability [37–39]. In these
studies, HIF-1a degradation despite being PHD-VHL-indepen-
dent is still proteasome-dependent [38,39]. Similarly, GSK3
mediated degradation of HIF-1a is also VHL-independent but
relies on the proteasome [40]. These are a few examples of direct
regulation of the HIF-a subunits. Our analysis revealed that HIF-
1b protects HIF-a subunits from degradation (Figure 6). HIF-1b
disruption by both curcumin and EF24 results in proteasome
independent degradation of HIF-1a even in hypoxia. How
curcumin regulates HIF-1b is still a matter of debate. While some
studies indicate the involvement of ubiquitin and the proteasome
[41], other studies demonstrate that curcumin disrupts HIF-1b
independent of the proteasome [42]. Of note, curcumin is known
to inhibit NF-kB in many different cellular backgrounds [43],
however, whether HIF-1b mRNA levels decrease in curcumin
treated cells has not been investigated.
HIF-2a levels have been shown to be high in macrophages at
normoxic levels and also in tumour areas, where near normal
levels of oxygen are present [44]. The mechanism behind the
increased HIF-2a levels in these areas has not been delineated thus
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Figure 8. NF-kB–mediated control of the HIF system is conserved in Drosophila. (A) Total RNA was extracted from control and Dorsal null
flies, and qPCR was performed for the levels of Drosophila HIF-1a, HIF-1b, PHD and ISWI. (B) Total RNA was extracted from control Dif, Relish and
Dorsal null flies, and qPCR was performed for the levels of the indicated genes. (C). Total RNA was extracted from control, UAS-Dorsal or Cactus null
flies, and qPCR was performed for the levels of the indicated genes. (D) Total RNA was extracted from control and Dorsal null flies exposed or not to
5% O2 for 24 hours. qPCR was performed for the levels of Drosophila HIF-1a, HIF-1b. (E) As in D, but qPCR was performed for the levels of Drosophila
PHD and Ldha. (F) Proposed model of NF-kB modulation of the HIF pathway. NF-kB directly regulates HIF-1a and HIF-1b genes. NF-kB induced HIF-1b
mediates HIF-2a stability.
doi:10.1371/journal.pgen.1001285.g008
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far. While it is possible, that PHD inhibition might take place, our
results demonstrate that NF-kB-mediated increases in HIF-1b,
induce HIF-2a protein, provide an alternative explanation.
However, the levels of HIF-1b under the conditions presented in
the published studies, have not been investigated.
NF-kB and the HIF pathways are conserved in flies [4,20].
While the VHL-PHD-dependent regulation has been shown to be
conserved in Drosophila [4], the relevance and conservation of NF-
kB-mediated control over HIF has not been previously estab-
lished. Our analysis of dorsal mutant flies (c-Rel homologue),
demonstrates that Dorsal controls the levels and activity of HIF
also in Drosophila (Figure 8). We also found that dorsal, sima and
tango are expressed in the head of the fly, a tissue we used for our
analysis (Figure S5).
Loss of function of dif, although reducing the levels of sima and
tango, does not alter Sima activity (Figure 8B), suggesting that the
observed reduction in mRNA levels of the HIF subunits is not
severe enough to have a functional effect at the protein level. Loss
of Relish, an additional NF-kB family member in the fly, resulted
in higher levels of sima, tango and its targets (Figure 8B). This
suggests that Relish acts a repressor of these genes. In mammalian
systems, it is well documented that p50 homodimers can act as
repressor forms of NF-kB [45,46], this is consistent with our
analysis of Relish mutants.
Our results also demonstrate that activation of NF-kB, assessed
by loss of function of Cactus and overexpression of Dorsal, will
lead to increased levels and activity of the HIF system (Figure 8C).
This raises the intriguing questions of whether in flies HIF is also a
part of the immune system and whether NF-kB mutations alter the
HIF response in hypoxia. These questions should thus be
addressed in future studies.
Recently, a study in Drosophila S2 cells demonstrated that the
levels of sima mRNA were hypoxia inducible [24]. Given these
findings, we determined the role of NF-kB in regulating this event.
Our results demonstrate that in adult flies, as observed in S2 cells,
hypoxia induces sima mRNA. Interestingly, we also observed
increases in tango mRNA levels. More importantly, we found that
these increases were dependent on Dorsal (Figure 8D). Function-
ally, inhibition of Dorsal led to significant reduction in the levels of
hypoxia-induced Sima-dependent genes (Figure 8E). This suggests
that NF-kB also plays a role in the regulation of hypoxia induced
HIF in Drosophila. Furthermore, it reveals that, as we had observed
in mammalian cells [47], NF-kB is activated following hypoxia in
the fly.
In summary, our results provide new evidence of the extensive
control of the HIF pathway by the Rel homology domain
containing transcription factor family, NF-kB, which is often
found deregulated in a number of human pathologies, including
cancer, autoimmune diseases and diabetes.
Materials and Methods
Cells
Human embryonic kidney cells HEK293 and human cervix
carcinoma HeLa cells were obtained from the ATCC. Mouse
Embryonic Fibroblasts were a kind gift from Prof. Ron Hay. All
cells were maintained at 5% CO2 in Dulbecco’s modified Eagle’s
medium (Lonza) supplemented with 10% fetal bovine serum (FBS)
(Invitrogen), 1% penicillin-streptomycin (Lonza), and 1% L-
glutamine (Lonza).
Treatments
TNF-a was obtained from Peprotech, dissolved in PBS and used
at a final concentration of 20 ng/mL, subsequent to medium
change. IKK inhibitor BAY 11-7082 and MG132 were purchased
from Merck Biosciences, dissolved in DMSO and used at a final
concentration of 20 mM.
Hypoxia treatments were performed in an InVIVO 300
hypoxia workstation (Ruskin, UK).
Plasmids
HIF-1b/ARNT expression plasmid was a kind gift from Prof.
O. Hankinson (UCLA, USA) and was transfected into cells using
the Calcium phosphate technique.
siRNA
siRNA oligonucleotides were purchased from MWG and used
in a final concentration of 36 nM. siRNA oligonucleotides were
transfected using the Calcium phosphate method (HEK293 and
HeLa) or using interferin from Polyplus according to manufac-
turer’s instructions.
siRNA sequences
Human
Control-59 -aac agu cgc guu ugc gac ugg- 39 [48]
RelA-59 -gcu gau gug cac cga caa g- 39 [48]
NF-kB-59-AAG GUG CAG AAA GAG GAC A-39
HIF-1b-59-GGU CAG CAG UCU UCC AUG A-39
HIF-1a-59- CUG AUG ACC AGC AAC UU-39 [15,49]
HIF-2a-59- CAG CAU CUU UGA CAG U-39
Mouse
IKKa, GCAGAAGAUUAUUGAUCUA [50]
IKKb, UGACGUGAAGCAUCUAGUA [50]
IKKc, GGAUUCGAGCAGUUAGUGA [50]
Drosophila strains and RNA preparation
Fly culture and husbandry was performed after standard
protocols. The amorphic dorsal alleles, dl1 and dl4 [51] were
crossed to obtain transheterozygous flies lacking dorsal function. To
generate cactus loss of function flies, the amorphic cact1 [52] allele
was crossed to Df(2L)r10 and cact1 hemizygous adult flies were
collected. For overexpression of dorsal, P[mata4-GAL-VP16] [53]
was used to drive expression of P[UAS-dl.H]2. Adult flies
homozygous for the loss of function alleles Dif1 and relE20 were
viable and fertile and maintained as stock [54,55]. As control an
isogenized white1118 stock was used. Hypoxia treatment was
performed for 24 hours at 25uC. For RNA preparations, groups
of 70 adult flies were frozen in liquid nitrogen and heads were
separated using a sieve. Total RNA was extracted using RNAeasy
extraction kit (Qiagen, Germany).
Quantitative PCR analysis
Total RNA was extracted with the Nucleospin RNA II isolation
system (Macherey Nagel; 740955) or Invisorb spin cell RNA
(Invitek), according to the manufacturer’s directions. RNA was
converted to cDNA using Quantitect Reverse Transcription Kit
(Qiagen). cDNA was used in semi-quantitative PCR. For
quantitative PCR, Brilliant II Sybr green kit (Stratagene/Agilent),
including specific MX3005P 96 well semi-skirted plates, were used
to analyse samples on the Mx3005P QPCR platform (Stratagene/
Agilent). Actin was used as a normalising gene in all experiments.
RT-qPCR sequences
Actin
For-CTGGGAGTGGGTGGAGGC
Rev-TCAACTGGTCTCAAGTCAGTG
GLUT3
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For- CAA TGC TCC TGA GAA GAT CAT AA
Rev-AAA GCG GTT GAC GAA GAG T
HIF-1a
For- CAT AAA GTC TGC AAC ATG GAA GGT
Rev-ATT TGA TGG GTG AGG AAT GGG TT
HIF-2a
For- GCG CTA GAC TCC GAG AAC AT
Rev-TGG CCA CTT ACT ACC TGA CCC TT
HIF-1b
For-CAA GCC CCT TGA GAA GTC AG
Rev-GAG GGG CTA GGC CAC TAT TC
PGK1
For-AAG TGA AGC TCG GAA AGC TTC TAT
Rev-AGG GAA AAG ATG CTT CTG GG
RelA
For-CTGCCGGGATGGCTTCTAT
Rev-CCGCTTCTTCACACACTGGAT
p100
For-AGCCTGGTAGACACGTACCG
Rev-CCGTACGCACTGTCTTCCTT
CYP1A1
For-GAGGCCAGAAGAAACTCCGT
Rev-CCCAGCTCAGCTCAGTACCT
CYP1B1
For-CTGCACTCGAGTCTGCACAT
Rev-TATCACTGACATCTTCGGCG
Fly primers.
drActin
For-GCGTTTTGTACAATTCGTCAGCAACC
Rev-GCACGCGAAACTGCAGCCAA
drHIF-1a (Sima)
For-AGCCCAATCTGCCGCCAACC
Rev-TGGAGGCCAGGTGGTGGGAC
drHIF-1b (Tango)
For-CGGCTGCTCATACGCCCGAG
Rev-GGCCAGCATGTGCGTCTGGT
drPHD (Fatiga)
For-TGGCCCGCCGAGGTAGACAA
Rev-CAGGCCCGTCTCCATCCCCA
drISWI
For-ACAGGTTGCACACTC GATTTTCAGT
Rev-CGGATGAACTGGTGGCCGCA
dLhda
For- CAGTTCGCAACGAACGCGCA
Rev- CAGCTCGCCCTGCAGCTTGT
Whole-cell protein lysates
Briefly, medium was aspirated and cells were washed once in
PBS and then resuspended in modified high salt whole cell
extraction buffer (20 mM HEPES pH7.6, 400 mM NaCl, 1 mM
EDTA, 25% glycerol, 0.1% NP-40, 1 mM dithiothreitol (DTT),
1 mM PMSF, 5 mM NAF, 500 mM Na3VO4, and 1 protease
inhibitor cocktail tablet (Roche) per 10 mL buffer). The cells were
lysed by incubating them at 4uC on a rotating wheel for 20
minutes before centrifugation at maximum speed for 15 minutes at
4uC.
Western blotting
Following SDS-PAGE, gels were transferred onto polyinylidine
difluoride (PVDF) membrane using a semi-dry transfer system.
Unless otherwise stated, western blots were incubated in primary
antibody at 4uC overnight, followed by a one hour incubation in
an HRP-linked secondary antibody solution and developed using
Enhanced chemo-luminescence (ECL) solution (PIERCE).
Immunoprecipitations
200 mg of whole cell lysates were used per immunoprecipitation
condition. Protein lystates were incubated overnight with 1 mg of
antibody in a rotating platform at 4C. 20 ml of packed protein-G-
sepharose beads were used to recover the immune-complexes, by
incubation for 2 hours at 4C in a rotating platform. Following 3
washes with PBS, complexes were eluted from the beads using
30 ml of SDS-loading buffer and boiled for 5 minutes prior to
being run in SDS-PAGE gels.
Antibodies
Antibodies used were: anti-HIF-1a (MAB1536, R&D Systems
and sc-10790, Santa Cruz), anti-HIF-1b (3718, Cell Signalling and
sc-5580, Santa Cruz), HIF-2a (NB100-122, Novus Biologicals),
anti-100/p52 polyclonal (sc-848, Santa Cruz), anti-RelA (sc-372,
Santa Cruz), anti-p105/p50 (sc-7178, Santa Cruz)), anti-RelB (sc-
48366, Santa Cruz), anti-cRel (sc-71, Santa Cruz) anti-PCNA
(P8825, Sigma), anti-Actin (A5441, Sigma), anti-Pol II (sc-47701,
Santa Cruz), anti-Glut3 (53520, AnaSpec), anti-AHR (SA-210,
Enzo Life Sciences).
Chromatin immunoprecipitation (ChIP)
Cells were grown in a 150 mm plate to 70% confluency and
cross-linked with 1% formaldehyde at room temperature for 10
minutes. Glycine was added to a final concentration of 0.125M for
5 m at room temperature. Cells were washed twice with 10 mL of
ice-cold phosphate-buffered saline (PBS) and then scraped into
2 mL ice cold harvest buffer (PBS, 1 mM phenylmethylsulfonyl
fluoride (PMSF), 1 mg/mL leupeptin, 1 mg/mL aprotinin) before
being centrifuged at 1000rpm in a Beckman & Coulter centrifuge at
4uC for 5 minutes. The supernatant was removed and the pellet was
resuspended in 400 mL of lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris-HCl, pH 8.1, 1 mM PMSF, 1 mg/mL leupeptin,
1 mg/mL aprotinin) and left on ice for 10 minutes. Samples were
then sonicated at 4uC eight times. Each sonication cycle lasted 15
seconds with a 30 second gap between each sonication using the
130W Sonics Vibracell. Supernatants were recovered by centrifu-
gation at 12,000rpm in an eppendorf microfuge for 10 minutes at
4uC before being diluted 10 fold in dilution buffer (1% Triton X-
100, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.1).
Samples were then pre-cleared for 2 hours at 4uC with 2 mg of
sheared salmon sperm DNA and 20 mL of protein A-Sepharose
(50% slurry). At this stage, 10% of the material was kept and stored
at –80uC as input material. Immunoprecipitations were performed
overnight with specific antibodies (1–2 mg depending on antibody),
with the addition of BRIJ-35 detergent to a final concentration of
0.1%. The immune complexes were captured by incubation with
30 mL of protein A-Sepharose (50% slurry) and 2 mg of single
stranded sheared salmon sperm DNA (Sigma) for 1 hour at 4uC.
The immunoprecipitates were washed sequentially for 5 m each at
4uC inWash Buffer 1 (0.1% SDS, 1% Triton X-100, 2 mMEDTA,
20 mM Tris-HCl, pH 8.1, 150 mM NaCl), Wash Buffer 2 (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.1,
500 mMNaCl), andWash Buffer 3 (0.25M LiCl, 1%Nonidet P-40,
1% deoxycholate, 1 mM EDTA, 10 mMTris-HCl, pH 8.1). Beads
were washed twice with Tris-EDTA (TE) buffer and eluted with
100 mL of Elution Buffer (1% SDS, 0.1M NaHCO3). Eluates were
purified using a DNA purification kit (NBS Biologicals). Samples
were then amplified using semi-quantitative PCR and analysed.
ChIP PCR sequences
HIF-1b Control
For- TTC CAC CCA TCC CCC TAT TTT
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Rev- ATG CAA AGC TGT TCA ATA GCA TAA
HIF-1b kB1
For-CCA GCG GGC AGA GGG TTA
Rev-ATC CCG GGG ACT TGG GTA GA
HIF-1b kB2/3
For-CGC GGA ATC CAA GAT GGC
Rev-GCC CTC CCT TCA CTG GAC
IkB-a
For-CTT AGA AGT CTG GGG AAA GCA AAT
Rev-GTA ATC CTG TCC CTC TGC AAG T
Statistical analysis
ANOVA and Student’s t-tests were performed on the means,
and p values were calculated. *, p#0.050; **, p#0.010 and
***, p#0.001.
Additional methods
Additional materials and methods can be found in Text S1.
Supporting Information
Figure S1 Depletion of NF-kB results in reduction in HIF-1a
but not HIF-2a mRNA levels. (A) U2OS and HEK293 cells
were transfected with control and pan-NF-kB siRNA oligonu-
cleotides for 48 hours prior to lysis. Whole cell lysates were
analysed by immunoblot using the indicated antibodies. (B)
HEK293 cells were tranfected with control and pan-NF-kB
siRNA oligonucleotides for 48 hours prior to lysis. Where
indicated cells were also treated with 20 ng/mL TNF-a prior to
total RNA extraction. qPCR was performed for the levels of
HIF-2a. (C) Cells were treated and processed as in B, but qPCR
was performed for HIF-1a.
Found at: doi:10.1371/journal.pgen.1001285.s001 (0.34 MB TIF)
Figure S2 IKK inhibition prevents NF-kB recruitment to the
HIF-1b promoter. HeLa cells were pre-treated with the IKK
inhibitor Bay 11 7082 for 30 minutes prior to TNF-a treatment.
Cells were crosslinked and lysed 24 hours later. ChIPs were
performed for the levels of cRel (A), and p52 (B), present at the
HIF-1b promoter. IkB-a promoter was used as a positive
control. (C) Schematic diagram of the HIF-1b promoter with
sequence alignment of the kB sites from human, gorilla, and
mouse.
Found at: doi:10.1371/journal.pgen.1001285.s002 (0.29 MB TIF)
Figure S3 HIF-1b is required for hypoxia induced HIF-1a.
U2OS cell stably expression control and HIF-1b shRNA
constructs were exposed to 1% O2 for the indicated periods of
time prior to lysis. Whole cell lysates were analysed by immunoblot
for the levels of the indicated proteins.
Found at: doi:10.1371/journal.pgen.1001285.s003 (0.21 MB TIF)
Figure S4 TNF-a represses AHR target genes via HIF-a subunit
levels. (A) HeLa cells were treated with 20 ng/mL TNF-a for the
indicated periods of time prior to RNA extraction. qPCR was
performed for the levels of HIF-1a, HIF-1b, and the AHR targets
CYP1A1 and CYP1B1. (B) HeLa cells were transfected with
control, HIF-1a or HIF-2a siRNA oligonucleotides for a total of
48 hours. Where indicated cells were treated with 20 ng/mL
TNF-a prior to total RNA extraction. qPCR was performed for
the levels of the indicated genes.
Found at: doi:10.1371/journal.pgen.1001285.s004 (0.22 MB TIF)
Figure S5 Sima, Tango, and Dorsal mRNA analysis in
development and adult tissues. qPCR analysis using Drosophila
tissue array. mRNA levels were normalised to RPL32 gene.
Found at: doi:10.1371/journal.pgen.1001285.s005 (0.14 MB TIF)
Text S1 Supplementary methods.
Found at: doi:10.1371/journal.pgen.1001285.s006 (0.02 MB
DOC)
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